Literature DB >> 7705035

Evaluation of the Etest for antimicrobial spectrum and potency determinations of anaerobes associated with bacterial vaginosis and peritonitis.

J L Croco1, M E Erwin, J M Jennings, L R Putnam, R N Jones.   

Abstract

One hundred ninety-seven anaerobic organisms (24 Gardnerella vaginalis, 16 Mobiluncus spp., 19 Peptostreptococcus spp., 20 Lactobacillus spp., 20 Prevotella bivia/disiens, 81 Bacteroides fragilis group, 12 Clostridium spp., and five Fusobacterium spp.) were processed by the Etest (AB Biodisk, Solna, Sweden) and a reference (Brucella blood agar) method against 10 antimicrobial agents. For the bacterial vaginosis-associated pathogens, the Etest was more reproducible and correlated acceptably with the reference agar test: within +/- 1 log2 dilution for 74.4% of Mobiluncus spp. to 96.0% for Peptostreptococcus spp. (all organisms, 83.4%). The quantitative correlation +/- 2 log2 dilution steps between test results was 94.3%. Results with B. fragilis group strains demonstrated 97.3% correlation (+/- 2 log2 dilution) with a trend toward slightly lower Etest minimum inhibitory concentrations for ampicillin-sulbactam, cefotaxime, imipenem, and clindamycin. The absolute qualitative interpretive agreement between Etest and the reference agar dilution method results was 94.4%, with only a 0.4% false-susceptible error rate. The Etest appears to be a very practical, quantitatively accurate, alternative procedure for clinical microbiology laboratories routinely testing the susceptibilities of anaerobes and, by these presented data, organisms associated with female tract infections.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7705035     DOI: 10.1016/0732-8893(94)90006-x

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  6 in total

1.  First comprehensive evaluation of the M.I.C. evaluator device compared to Etest and CLSI reference dilution methods for antimicrobial susceptibility testing of clinical strains of anaerobes and other fastidious bacterial species.

Authors:  R P Rennie; L Turnbull; C Brosnikoff; J Cloke
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

2.  Evaluation of new broth media for microdilution antibiotic susceptibility testing of Lactobacilli, Pediococci, Lactococci, and Bifidobacteria.

Authors:  Ingo Klare; Carola Konstabel; Sibylle Müller-Bertling; Rolf Reissbrodt; Geert Huys; Marc Vancanneyt; Jean Swings; Herman Goossens; Wolfgang Witte
Journal:  Appl Environ Microbiol       Date:  2005-12       Impact factor: 4.792

Review 3.  Antianaerobic antimicrobials: spectrum and susceptibility testing.

Authors:  Itzhak Brook; Hannah M Wexler; Ellie J C Goldstein
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

Review 4.  Cefotaxime. A reappraisal of its antibacterial activity and pharmacokinetic properties, and a review of its therapeutic efficacy when administered twice daily for the treatment of mild to moderate infections.

Authors:  R N Brogden; C M Spencer
Journal:  Drugs       Date:  1997-03       Impact factor: 9.546

5.  Lactobacillus species identification, H2O2 production, and antibiotic resistance and correlation with human clinical status.

Authors:  A Felten; C Barreau; C Bizet; P H Lagrange; A Philippon
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

6.  Antibiotic susceptibility of Atopobium vaginae.

Authors:  Ellen De Backer; Rita Verhelst; Hans Verstraelen; Geert Claeys; Gerda Verschraegen; Marleen Temmerman; Mario Vaneechoutte
Journal:  BMC Infect Dis       Date:  2006-03-16       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.